FMR1 and fragile X syndrome: These findings highlight the critical role of 5hmC in the FMR1 gene’s epigenetic regulation in FXS and point to the need for future therapeutic strategies targeting this pathway to restore FMR1 expression while also indicating that current cellular models may not fully capture the disease’s epigenetic nuances.